Stoke Therapeutics

(NASDAQ) STOK

Current Price$33.07

Market Cap$2.06B

Since IPO (2019)+28%

5 Year+2%

1 Year+235%

1 Month+3%

Stoke Therapeutics Financials at a Glance

Market Cap

$2.06B

Revenue (TTM)

$184.42M

Net Income (TTM)

$6.88M

EPS (TTM)

$-0.15

P/E Ratio

-222.76

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$33.07

Volume

16,555

Open

$32.53

Price

$33.07

Volume

16,555

Open

$32.53

Previous Close

$33.07

Daily Range

$32.44 - $33.52

52-Week Range

$8.30 - $40.22

Dividend

$0.00

Beta (Volatility)

1.39 (Average)

Price

$33.07

Volume

16,555

Open

$32.53

Previous Close

$33.07

Daily Range

$32.44 - $33.52

52-Week Range

$8.30 - $40.22

STOK News

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Jonathan PoncianoMar 27, 2026

Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally

Jonathan PoncianoMar 24, 2026

Stoke Therapeutics' Chief Medical Officer Sold Over 5,000 Shares in the Company. Should Shareholders Sell?

Robert IzquierdoDec 10, 2025

Are There Good Investments Among 2019's Biotech IPOs?

David HaenOct 2, 2019

STOK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stoke Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

170

CEO

Ian Frederick Smith, CPA

Website

www.stoketherapeutics.com

Headquarters

Bedford, MA 01730, US

STOK Financials

Key Financial Metrics (TTM)

Gross Margin

99%

Operating Margin

-11%

Net Income Margin

-4%

Return on Equity

-2%

Return on Capital

-6%

Return on Assets

-2%

Earnings Yield

-0.45%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.06B

Shares Outstanding

62.27M

Volume

16.55K

Avg. Volume

732.09K

Financials (TTM)

Gross Profit

$184.42M

Operating Income

$20.59M

EBITDA

$18.82M

Operating Cash Flow

$45.59M

Capital Expenditure

$670.00K

Free Cash Flow

$44.91M

Cash & ST Invst.

$284.67M

Total Debt

$0.00

Stoke Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.40M

-93.8%

Gross Profit

$347.00K

-98.5%

Gross Margin

24.75%

N/A

Market Cap

$2.06B

N/A

Market Cap/Employee

$16.09M

N/A

Employees

128

N/A

Net Income

$57.93M

-452.7%

EBITDA

$60.38M

-360.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$284.67M

+32.7%

Accounts Receivable

$7.91M

+1029.3%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.65%

N/A

Return on Invested Capital

-5.71%

N/A

Free Cash Flow

$30.69M

-32.1%

Operating Cash Flow

$30.45M

-31.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

ZYMEZymeworks Inc.

ZYMEZymeworks Inc.$26.61-3.36%

BCRXBioCryst Pharmaceuticals, Inc.

BCRXBioCryst Pharmaceuticals, Inc.$9.19+0.27%

PHVSPharvaris N.V.

PHVSPharvaris N.V.$29.44-5.06%

ARDXArdelyx, Inc.

ARDXArdelyx, Inc.$6.88+8.69%

NTLAIntellia Therapeutics, Inc.

NTLAIntellia Therapeutics, Inc.$13.26-1.63%

WVEWave Life Sciences Ltd.

WVEWave Life Sciences Ltd.$7.32+3.68%

NVAXNovavax, Inc.

NVAXNovavax, Inc.$8.04+1.45%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About STOK

What is the current price of Stoke Therapeutics?

Stoke Therapeutics is trading at $33.07 per share.

What is the 52-week range for Stoke Therapeutics?

Over the past 52 weeks, Stoke Therapeutics has traded between $8.30 and $40.22.

How much debt does Stoke Therapeutics have?

As of the most recent reporting period, Stoke Therapeutics reported total debt of $4.15M.

How much cash does Stoke Therapeutics have on hand?

Stoke Therapeutics reported $84.71M in cash and cash equivalents in its most recent financial results.

What is Stoke Therapeutics’s dividend yield?

Stoke Therapeutics does not currently have a dividend yield.

Stoke Therapeutics

Stoke Therapeutics Financials at a Glance

STOK News

Stoke Therapeutics Stock Up 340% as Chair Sells $174K in Shares

Stoke Therapeutics CMO Sells $457,000 in Stock Amid 300% Rally

Stoke Therapeutics' Chief Medical Officer Sold Over 5,000 Shares in the Company. Should Shareholders Sell?

This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street

Why Shares of Stoke Therapeutics Plummeted Tuesday

Why Shares of Stoke Therapeutics Plummeted in September

Are There Good Investments Among 2019's Biotech IPOs?

STOK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Stoke Therapeutics

STOK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Stoke Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About STOK

What is the current price of Stoke Therapeutics?

What is the 52-week range for Stoke Therapeutics?

How much debt does Stoke Therapeutics have?

How much cash does Stoke Therapeutics have on hand?

What is Stoke Therapeutics’s dividend yield?

Premium Investing Services